In CMS mouse model, BDNF signaling pathway in the hippocampus was boosted due to Rg2 administration, which inhibited the depression-like effects induced by CMS, and knocking out TrkB can entirely block the antidepressant effect of Rg2 in mice (Ren et al., 2017). This evidence concerns the gene BDNF and major depressive disorder.